(6-Hydroxynaphthalen-2-yl)boronic acid

We are (6-Hydroxynaphthalen-2-yl)boronic acid CAS:173194-95-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: (6-Hydroxynaphthalen-2-yl)boronic acid
Other Name:
(6-Hydroxynaphthalen-2-yl)boronic acid
6-Hydroxynaphthalene-2-boronic acid
6-Hydroxy-2-naphthaleneboronic acid
6-Hydroxy-2-naphthylboronic Acid
CAS No: 173194-95-1
MF: C10H9BO3
MW: 187.98800
Density: 1.35g/cm3
Boiling point: 458.6ºC at 760mmHg
Melting point: 218-224°C
Flash point: 231.1ºC
Refractive index: 1.681
UN Number: UN1993
Transport hazard class: 3
Packing group: II
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(6-Hydroxynaphthalen-2-yl)boronic acid


Related News: Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.Veratrole CAS:91-16-7 At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.Dimethyl terephthalate This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.821-48-7 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.

Related Products
Product Name
4-tert-Butylphenyl isothiocyanate View Details
Cytidine 5′-monophosphate disodium salt View Details
2,4-Dichloro-5-fluorobenzoyl chloride View Details
4-Chloro-3-nitrotoluene manufacturer Suberic Acid Monomethyl Ester manufacturer 2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride manufacturer 4-Bromo-3-nitrobenzotrifluoride manufacturer 9H-Purine-2,6-diamine, 9-.β.-D-ribofuranosyl- manufacturer